SAFE-BioPharma - A new domain standard for secure identity
In medical and pharmaceutical research, researchers deal with sensitive private information on a daily basis. That makes secure identity management a crucial need. Mollie Shields-Uehling is the CEO of the SAFE-BioPharma Association, a non-profit organization charged with creating a standard that meets that need.
SAFE-BioPharma Association is a non-profit industry collaboration established by the world's leading biopharmaceutical companies to develop and maintain a global interoperable digital identity and signature standard for the biopharmaceutical and healthcare communities.
To read the full interview with Mrs. Mollie Shields-Uehling, CEO of the SAFE-BioPharma Association please click here
Source iSGTW newsletter - Miriam Boon
| Area of interest |
|
|---|










